S
Supernus Pharmaceuticals (SUPN)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Supernus Pharmaceuticals (SUPN)
Supernus Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. The Company offers Oxtellar XR (extended-release oxcarbazepine) and Trokendi XR (exten... Read more
- USD31.54
- USD32.22
- USD31.21
- USD40.28
- -0.20%
- 668M
- 162.00
- 458.71k
- 1.8B
- 25.53
- 5.70%
- 15.00%
Stock News
3 hours ago
How Bessent explained the 115-point reduction in U.S.-China tariffs that has triggered market euphoria
MarketWatch
8 hours ago
The 1-Minute Market Report - May 11, 2025
SeekingAlpha
8 hours ago
YYY: Stretching For An Amplified Yield Of 12.8%
SeekingAlpha
9 hours ago
US Foods: Margin Expansion Priced In, Initiate At Hold
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
